Arcadia Biosciences (NASDAQ:RKDA) Stock Passes Below 50-Day Moving Average – Here’s What Happened

Arcadia Biosciences, Inc. (NASDAQ:RKDAGet Free Report) passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $0.60 and traded as low as $0.4501. Arcadia Biosciences shares last traded at $0.4797, with a volume of 34,400 shares traded.

Analyst Ratings Changes

Separately, Weiss Ratings downgraded Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, June 25th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has an average rating of “Sell”.

Read Our Latest Stock Report on Arcadia Biosciences

Arcadia Biosciences Price Performance

The stock has a market capitalization of $1.16 million, a price-to-earnings ratio of -0.11 and a beta of 0.53. The stock’s 50 day simple moving average is $0.60 and its 200-day simple moving average is $1.03.

Arcadia Biosciences (NASDAQ:RKDAGet Free Report) last announced its quarterly earnings results on Thursday, August 13th. The basic materials company reported ($2.09) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.56) by ($1.53). The company had revenue of $1.44 million during the quarter, compared to analyst estimates of $1.90 million. Arcadia Biosciences had a negative return on equity of 183.50% and a negative net margin of 234.53%.

Arcadia Biosciences Company Profile

(Get Free Report)

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.

Recommended Stories

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.